These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17985242)

  • 1. A pilot study of efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis.
    Cai Q; Barrie M; Olejeme H; Rosenberg MD
    Dig Dis Sci; 2008 Jun; 53(6):1500-5. PubMed ID: 17985242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pantoprazole in older patients with erosive esophagitis.
    DeVault KR; Morgenstern DM; Lynn RB; Metz DC
    Dis Esophagus; 2007; 20(5):411-5. PubMed ID: 17760655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE; Bochenek W
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.
    Madrazo-de la Garza A; Dibildox M; Vargas A; Delgado J; Gonzalez J; Yañez P
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):261-5. PubMed ID: 12548064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis.
    Moretzsohn LD; Brito EM; Reis MS; Coelho LG; Castro Lde P
    Arq Gastroenterol; 2002; 39(2):123-5. PubMed ID: 12612717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.
    Cho YK; Choi MG; Bak YT; Rhee PL; Kim SG; Jung HY; Seol SY
    Dig Dis Sci; 2012 Dec; 57(12):3189-94. PubMed ID: 22772870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
    Pratha V; Hogan DL; Lynn RB; Field B; Metz DC
    Dig Dis Sci; 2006 Sep; 51(9):1595-601. PubMed ID: 16927137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G; Cain C; Malfertheiner P
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD; Van Rensburg C
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.